Characteristics of Hospitalized COVID-19 Patients at Panyananthaphikkhu Chonprathan Medical Center, Srinakharinwirot University, Thailand
Keywords:
COVID-19, hospitalized patients, clinical characteristics, retrospective study Emerging DiseaseAbstract
Background: COVID-19 is an emerging disease that emerged in late 2019, causing great losses to the global health system. As a result, many patients require hospitalization due to complications and leading to a significant number of fatalities. There were previous studies about the characteristics of COVID-19 patients in many populations’ groups around the world. However, the data was still limited in Thailand. Objective: To study the characteristics of COVID-19 patients hospitalized Method: The retrospective study, that collected hospitalize patients’ data from January 2020 to December 2023 at the Panyananthaphikkhu Chonprathan Medical Center, Srinakharinwirot University. All patients were confirmed diagnosis of COVID-19 from polymerase chain reaction (PCR). The data were analyzed using descriptive statistics. Results: A total of 1,084 patients were found, of which 621 cases (57.29%) were female, 463 cases (42.71%) were male. Patients older than 75 years were most common found at 329 cases (30.35%), The patients had underling diseases were 981 cases (82.65%), the most patients with hypertension 634 cases (58.49%), dyslipidemia 504 cases (46.49%), diabetes mellitus 347 cases (32.01%). The majority of patients had moderately severe symptoms, found 521 cases (50.05%). Cough was the most common symptom, found at 718 cases (66.24%), followed by phlegm, fatigue, sore throat/itchy throat, runny nose, stuffy nose, loss of smell or taste, 573 cases (52.86%), 375 cases (34.59%), 258 cases (23.80%), 246 cases (22.69 %), 176 cases (16.24%) 59 cases (5.44%) respectively. The mortality rate was 175 cases (16.14%) and the complications found 737 cases (67.98%), the main of complication was pneumonia fellow to septic shock, acute respiratory distress syndrome (ARDS) and congestive heart failure were 732 cases (67.63%), 50 cases (4.61%), 31 cases (2.86 %), 9 cases (0.83%) respectively. Conclusion: Characteristics of COVID-19 patients In Thailand, the majority are elderly. Mortality and complications rates, especially in ARSD, are lower than in past studies. However, more studies are needed. To lead to appropriate treatment and prevention plans for Thai people in the future. Results: A total of 1,084 patients were found, separated into 57.29% women, 42.71% men. The most were people over 75 years old, 30.35%, and the least patients were found were those aged < 15 years, 5.17%. The patients with underling diseases were total 82.65%, separated into hypertension 58.49%, dyslipidemia 46.49%, diabetes mellitus 32.01%, heart disease 8.86%, asthma/Allergic rhinitis 4.70%, immunocompromised 1.57%, cirrhosis 1.48%, The median of body mass index: BMI was 24.57(IQR;7.01; [10.96, 49.48]. The patients show moderate symptoms 50.05%. Cough is the most common of symptoms, that found 66.24%and phlegm, fatigue, sore throat/itchy throat, runny nose, stuffy nose, loss of smell or taste, 52.86%, 34.59%, 23.80%, 22.69 %, 16.24% 5.44% respectively. The patients died 16.14%, Patients with complications found 67.98%, the most complication was pneumonia, septic shock, acute respiratory distress syndrome (ARDS), congestive heart failure were 67.63%, 4.61%, 2.86 %, 0.83% respectively. Conclusion: COVID-19 is a serious emerging disease that results in death and many complications in patients. Symptoms and complications found in Thai people are different from studies abroad, which requires further study.
Downloads
References
Okada P, Buathong R, Phuygun S, et al. Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020. Euro Surveill. 2020;25(8):2000097. doi:10.2807/1560-7917.ES.2020.25 .8.20 00097
WHO. Coronavirus disease (COVID-19) pandemic. [Online]. 2021 .https://www. who. int/emergencies/diseases/novel-coronavirus-2019. Accessed August 9, 2021
U.S. Centers for Disease Control and Prevention (CDC). Symptoms of COVID-19. [Online].2021.https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symp toms.html. Accessed August 9, 2021.
WHO. WHO Coronavirus (COVID-19) Dashboard. [Online]. 2021. https://covid19. who.int/. Accessed February 10, 2024.
WHO. Thailand Situation. [Online]. 2021 . https://covid19.who.int/region/searo/coun try/th. Accessed February 10, 2024.
Department of Medical Services, Ministry of Public Health, Thailand. Guidelines for Clinical Practice, Diagnosis, Treatment and Prevention of Healthcare-Associated Infection in Response to Patients with COVID-19 Infection for Medical and Healthcare Personnel 2023.https://covid19.dms.go.th/backend ///Content/Content_FIle/Bandner_(Big)/Attach/25660418150440PM_CPG_COVID-19_v.27_n_18042023.pdf. Accessed January 22, 2024
Kramer MS, Papageorghiou A, Culhane J, et al. Challenges in defining and classifying the preterm birth syndrome. Am J Obstet Gynecol. 2012;206(2):108-112. doi:10.1016/j.ajog.2011.10.864
Machin D. Sample size table for clinical studies. 2nd ed. Science OB, editor
Noordzij M, Dekker FW, Zoccali C, Jager KJ. Study designs in clinical research. Nephron Clin Proact. 2009;113(3):c218-c221. doi:10.1159/000235610
Department of Disease Control, Ministry of Public Health, Thailand, Report Covid-19 cases on 31 July 2021 [Online]. 2021 . https://ddc.moph.go.th/dir/index.php. Accessed August 31, 2021.
Callaway E. The coronavirus is mutating - does it matter?. Nature. 2020;585 (7824) :174-177. doi:10.1038/d41586-020-02544-6
Li X, Luk HKH, Lau SKP, Woo PCY. Human Coronaviruses: General Features . Reference Module in Biomedical Sciences. 2019;B978-0-12-801238-3.95704-0. doi:10.1016/B978-0-12-801238-3.95704-0
WHO. The effects of virus variants on COVID-19 vaccines. [Online]. 2021 https://www.who.int/news-room/featurestories/detail/the-effects-ofvirus variants-oncovid19vaccines?gclid=CjwKCAjwpMOIBhBAEiwAy5M6YH8 kd0C0hh3Zeh_4a FJXtl6qTQIgLxK6ysfhi7NCHD6hHSq1keBOBoCsbcQAvD_BwE. Accessed August 9, 2023.
Hatmi ZN. A Systematic Review of Systematic Reviews on the COVID-19 Pandemic. SN Compr Clin Med. 2021;3(2):419-436. doi:10.1007/s42399-021-00749-y
Pongpirul WA, Wiboonchutikul S, Charoenpong L, et al. Clinical course and potential predictive factors for pneumonia of adult patients with Coronavirus Disease 2019 (COVID-19): A retrospective observational analysis of 193 confirmed cases in Thailand. PLoS Negl Trop Dis. 2020;14(10):e0008806. Published 2020 Oct 16. doi:10.1371/journal.pntd.0008806
Hu FH, Jia YJ, Zhao DY, et al. Clinical outcomes of the severe acute respiratory syndrome coronavirus 2 Omicron and Delta variant: systematic review and meta-analysis of 33 studies covering 6 037 144 coronavirus disease 2019-positive patients. Clin Microbiol Infect. 2023;29(7):835-844. doi:10.1016/ j.cmi.2023.03.017
Miyashita K, Hozumi H, Furuhashi K, et al. Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study. Emerg Microbes Infect. 2023;12(1):2155250. doi:10.1080/22221751.2022.2155250
Luers JC, Rokohl AC, Loreck N, et al. Olfactory and Gustatory Dysfunction in Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2020;71(16):2262-2264. doi:10.1093/cid/ciaa525
Zambrano LD, Ellington S, Strid P, et al. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(44):1641-1647. Published 2020 Nov 6. doi:10.15585/mmwr.mm 6944e3
Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320. Published 2020 Sep 1. doi:10.1136/bmj.m3320
Yanes-Lane M, Winters N, Fregonese F, et al. Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: A systematic review and meta-analysis. PLoS One. 2020;15(11):e0241536. Published 2020 Nov 3. doi:10.1371/journal.pone.0241536
Badr DA, Mattern J, Carlin A, et al. Are clinical outcomes worse for pregnant women at ≥20 weeks' gestation infected with coronavirus disease 2019? A multicenter case-control study with propensity score matching. Am J Obstet Gynecol. 2020;223 (5):764-768. doi:10.1016/j.ajog.2020.07.045
Metz TD, Clifton RG, Hughes BL, et al. Disease Severity and Perinatal Outcomes of Pregnant Patients With Coronavirus Disease 2019 (COVID-19). Obstet Gynecol. 2021;137(4):571-580. doi:10.1097/AOG.0000000000004339
Quadax F, Mensah NA, Tingey B, Stanford JB. The risk of clinical complications and death among pregnant women with COVID-19 in the Cerner COVID-19 cohort: a retrospective analysis. BMC Pregnancy Childbirth. 2021;21(1):305. Published 2021 Apr 16. doi:10.1186/s12884-021-03772-y
DeBolt CA, Bianco A, Limaye MA, et al. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls. Am J Obstet Gynecol. 2021;224(5):510.e1-510.e12. doi:10.1016/j.ajog.2020.11.022
Lokken EM, Huebner EM, Taylor GG, et al. Disease severity, pregnancy outcomes, and maternal deaths among pregnant patients with severe acute respiratory syndrome coronavirus 2 infection in Washington State. Am J Obstet Gynecol. 2021;225(1):77.e1-77.e14. doi:10.1016/j.ajog.2020.12.1221
Dawood FS, Varner M, Tita A, et al. Incidence and Clinical Characteristics of and Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Pregnant Individuals in the United States. Clin Infect Dis. 2022;74(12):2218-2226. doi:10.1093/cid/ciab713
Martinez-Portilla RJ, Sotiriadis A, Chatzakis C, et al. Pregnant women with SARS-CoV-2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort (COV19Mx). Ultrasound Obstet Gynecol. 2021;57(2):224-231. doi:10.1002/uog.23575
Kotlyar AM, Grechukhina O, Chen A, et al. Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis. Am J Obstet Gynecol. 2021;224(1):35-53.e3. doi:10.1016/j.ajog.2020.07.049
Woodworth KR, Olsen EO, Neelam V, et al. Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(44):1635-1640. Published 2020 Nov 6. doi:10.15585/mmwr.mm6944e2
Cosma S, Carosso AR, Cusato J, et al. Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients. Am J Obstet Gynecol. 2021;224(4):391.e1-391.e7. doi:10.1016/j.ajog. 2020.10.005
la Cour Freiesleben N, Egerup P, Hviid KVR, et al. SARS-CoV-2 in first trimester pregnancy: a cohort study. Hum Reprod. 2021;36(1):40-47. doi:10.1093/humrep/ deaa311
Rotshenker-Olshinka K, Volodarsky-Perel A, Steiner N, Rubenfeld E, Dahan MH. COVID-19 pandemic effect on early pregnancy: are miscarriage rates altered, in asymptomatic women?. Arch Gynecol Obstet. 2021;303(3):839-845. doi:10.1007/ s00404-020-05848-0
Jacoby VL, Murtha A, Afshar Y, et al. Risk of pregnancy loss before 20 weeks' gestation in study participants with COVID-19. Am J Obstet Gynecol. 2021;225(4) :456-457. doi:10.1016/j.ajog.2021.06.080
Delahoy MJ, Whitaker M, O'Halloran A, et al. Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 - COVID-NET, 13 States, March 1-August 22, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(38):1347-1354. Published 2020 Sep 25. doi:10.15585/ mmwr.mm6938e1
Panagiotakopoulos L, Myers TR, Gee J, et al. SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics - Eight U.S. Health Care Centers, March 1-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(38):1355-1359. Published 2020 Sep 23. doi:10.15585/mmwr.mm6938e2
Hoyert DL, Gregory EC. Cause of Fetal Death: Data From the Fetal Death Report, 2014. Natl Vital Stat Rep. 2016;65(7):1-25.
Li X, Guan B, Su T, et al. Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis. Heart. 2020;106(15):1142-1147. doi:10.1136/heartjnl-2020-317062
Jayanama K, Srichatrapimuk S, Thammavaranucupt K, et al. The association between body mass index and severity of Coronavirus Disease 2019 (COVID-19): A cohort study. PLoS One. 2021;16(2):e0247023. Published 2021 Feb 16. doi:10.1371/journal.pone.0247023
Niyatiwatchanchai N, Deesomchok A, Chaiwong W, et al. Comparative Study of Early Impacts of Post-COVID-19 Pneumonia on Clinical Manifestations, Pulmonary Function, and Chest Radiographs. Medicina (Kaunas). 2022;58(2):216. Published 2022 Feb 1. doi:10.3390/medicina58020216
Kulbun A, Tovichien P, Chaiyakulsil C, et al. Chest X-ray findings of COVID-19 pneumonia in children: Experiences in a multicenter study in Thailand. PLoS One. 2024;19(9):e0309110. Published 2024 Sep 30. doi:10.1371/journal.pone .0309110
Akhmerov A, Marbán E. COVID-19 and the Heart. Circ Res. 2020;126(10):1443-1455. doi:10.1161/CIRCRESAHA.120.317055
Sugimoto T, Mizuno A, Kishi T, et al. Coronavirus Disease 2019 (COVID-19) Information for Cardiologists - Systematic Literature Review and Additional Analysis. Circ J. 2020;84(6):1039-1043. doi:10.1253/circj.CJ-20-0302
Mao R, Qiu Y, He JS, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis [published correction appears in Lancet Gastroenterol Hepatol. 2020 Jul;5(7):e6. doi: 10.1016/S2468-1253(20)30160-6]. Lancet Gastroenterol Hepatol. 2020;5(7): 667-678. doi:10.1016/S2468-1253(20)30126-6
Siordia JA Jr. Epidemiology and clinical features of COVID-19: A review of current literature. J Clin Virol. 2020;127:104357. doi:10.1016/j.jcv.2020.104357
Bruminhent J, Ruangsubvilai N, Nabhindhakara J, Ingsathit A, Kiertiburanakul S. Clinical characteristics and risk factors for coronavirus disease 2019 (COVID-19) among patients under investigation in Thailand. PLoS One. 2020;15(9):e0239250. Published 2020 Sep 15. doi:10.1371/journal.pone.0239250
Gupta GS. The Lactate and the Lactate Dehydrogenase in Inflammatory Diseases and Major Risk Factors in COVID-19 Patients. Inflammation. 2022;45(6):2091-2123. doi:10.1007/s10753-022-01680-7
U.S. Centers for Disease Control and Prevention (CDC). Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19); U.S. Centers for Disease Control and Prevention (CDC): GA, US 2020. [Online]. 2020 . https://stacks.cdc.gov/view/cdc/89980. Accessed February 10, 2024.

Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Chulabhorn Royal Academy

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของราชวิทยาลัยจุฬาภรณ์
ข้อความที่ปรากฏในบทความแต่ละเรื่องในวารสารวิชาการเล่มนี้เป็นความคิดเห็นส่วนตัวของผู้เขียนแต่ละท่านไม่เกี่ยวข้องกับราชวิทยาลัยจุฬาภรณ์ และคณาจารย์ท่านอื่น ในราชวิทยาลัยฯ แต่อย่างใด ความรับผิดชอบองค์ประกอบทั้งหมดของบทความแต่ละเรื่องเป็นของผู้เขียนแต่ละท่าน หากมีความผิดพลาดใด ๆ ผู้เขียนแต่ละท่านจะรับผิดชอบบทความของตนเองแต่ผู้เดียว